Test Price
850 AED✅ Home Collection Available
OsteoScreen Panel (Bone Profile) in UAE | 850 AED | DHA Licensed
Executive Summary & Core Metrics
Integrated bone health assessment with 99.9% diagnostic sensitivity through ISO-accredited processing. This panel quantifies key bone turnover markers to evaluate skeletal metabolism, detect osteoporosis, and monitor anti-resorptive therapy.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary telephonic post-test consultation for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The OsteoScreen Panel is a comprehensive bone turnover assay that measures markers of bone formation (P1NP) and bone resorption (Beta-CTX) to precisely assess skeletal metabolism. This advanced profile aids in diagnosing osteoporosis, osteopenia, and metabolic bone disease while monitoring the efficacy of anti-resorptive or bone-forming therapies. Results must be interpreted in conjunction with clinical history, imaging, and fracture risk assessment tools.
Comparative Test Features
| Feature | Our OsteoScreen Panel | Standard Bone Panel |
|---|---|---|
| Methodology | CLIA + Spectrophotometry (LC-MS/MS validated) | Manual ELISA or outdated colorimetric assays |
| Precision | 99.9% sensitivity, CV <5% | Varies widely, often >10% CV |
| Turnaround Time | Same-day reporting (daily batch processing) | 3–5 working days |
| Sample Stability | Rigorous cold-chain, frozen at -20°C within 30 min | Ambient transport, risk of degradation |
Physician Insight & Safety Protocols
Dr. Ajay Singh (General Practitioner | DHA Registration ID: 36234132) advises: “The OsteoScreen Panel provides a functional snapshot of bone turnover dynamics. These quantitative results must be correlated with the patient’s clinical presentation, imaging findings, and fracture risk profile. Self-diagnosis or unauthorised medication adjustments based solely on lab values carry significant clinical risk. Any abnormal findings warrant a comprehensive metabolic workup and specialist referral.”
Important Patient Advisory
⚠ Critical Medication Safety
- Never discontinue or alter prescribed osteoporosis medications (bisphosphonates, denosumab, teriparatide) without direct consultation with your treating physician.
- Results from this panel reflect bone turnover at the time of collection and may be influenced by recent fractures, acute illness, or changes in therapy.
- Always share your complete medication history, including calcium and vitamin D supplements, with your healthcare provider during the post-test consultation.
Exclusion Criteria & Sample Integrity
- Exclusion Criteria: Acute febrile illness, recent fracture (within 3 months), active malignancy, pregnancy (relative contraindication).
- Sample Integrity: Collect fasting between 8:00–10:00 AM. Separate serum and freeze at -20°C within 30 minutes of collection. Do Not Thaw prior to analysis.
- Emergency Red Flags: Sudden severe bone pain, unexplained height loss, or new neurological deficits require immediate emergency department evaluation and are not suitable for routine outpatient testing.
Patient FAQ & Clinical Guidance
1. What is the OsteoScreen Panel and what specific bone markers does it measure?
The OsteoScreen Panel is a quantitative bone turnover assessment that measures P1NP (procollagen type I N-terminal propeptide), a marker of bone formation, and Beta-CTX (C-terminal telopeptide), a marker of bone resorption. These two biomarkers provide a dynamic view of skeletal remodelling and are essential for diagnosing osteoporosis, monitoring anti-resorptive therapy, and assessing fracture risk in at-risk populations.
2. What are the preparation instructions and sample requirements for this test?
A fasting blood sample (8–12 hours) must be collected between 8:00 and 10:00 AM. A 4 mL serum sample is required, which must be separated and frozen at -20°C within 30 minutes of collection. Samples must remain frozen during transport—do not thaw. Our VIP Mobile Phlebotomy service handles collection at your home or office between 8 AM and 11 PM daily, using temperature-controlled cold-chain logistics compliant with DHA standards.
3. How quickly will I receive my results and what post-test support is provided?
Your digital report is delivered within 24 hours via secure email, with same-day processing for samples received by 10 AM. A dedicated clinical team offers a complimentary telephonic post-test guidance session to interpret your results in the context of your medical history and ongoing treatments, ensuring you understand your bone health status and any recommended follow-up actions.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
All clinical testing and data handling at DNA Labs UAE strictly adhere to:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) — governing the collection, processing, and storage of personal health data with stringent consent and security requirements.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields — regulating telehealth, electronic health records, and digital diagnostic data exchange.
- Federal Decree-Law No. 4 of 2016 on Medical Liability — establishing the legal framework for clinical responsibility, patient consent, and safety in diagnostic procedures.
Your health information is encrypted, access-controlled, and processed exclusively within UAEjurisdiction. No data is shared with third parties without explicit written consent.
Clinical & Logistical Metadata
| Test Name | OsteoScreen Panel (Bone Profile) |
| Price (AED) | 850 AED |
| Turnaround Time | Same-day processing; digital report within 24 hours |
| Sample Type / Matrix | Serum (peripheral whole blood) |
| Methodology Used | CLIA + Spectrophotometry (LC-MS/MS validated) |
| ICD-10-CM Code | Z13.820 |
| LOINC Code | 24320-4 |
| DHA Facility License & Address | DHA Facility License Number: 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians